ArticleAnnals of hematology2023

Ibrutinib plus rituximab and lenalidomide for primary intestinal diffuse large B-cell lymphoma relapsed after anti-CD19 CAR-T cell therapy: a case report.

Changyou Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.